Several problems about the stereotactic body radiation therapy for lung cancer
10.3760/cma.j.issn.1673-422X.2018.03.011
- VernacularTitle:立体定向放疗治疗肺部肿瘤的几个问题
- Author:
Chuanghuang SU
1
;
Derui LI
Author Information
1. 515000,汕头大学医学院肿瘤医院放疗科
- Keywords:
Carcinoma,non-small-cell lung;
Stereotactic body radiation therapy
- From:
Journal of International Oncology
2018;45(3):176-179
- CountryChina
- Language:Chinese
-
Abstract:
As the first treatment of choice for medically inoperable patients with early stage non-small cell lung cancer,it is demonstrated that the therapeutic outcome of stereotactic body radiation therapy (SBRT)is similar to that of surgery,but the data is mainly from nonrandomized controls and retrospective studies.More cases of randomized prospective clinical trials are needed to confirm the conclusions.The biologically effective dose ＞ 100 Gy is associated with improved local control and overall survival,and the small tumor volume is correlated with higher local control rate.
